Abstract
Production of glycoprotein therapeutics in Chinese hamster ovary (CHO) cells is limited by the cells' generic capacity for N-glycosylation, and production of glycoproteins with desirable homogeneous glycoforms remains a challenge. We conducted a comprehensive knockout screen of glycosyltransferase genes controlling N-glycosylation in CHO cells and constructed a design matrix that facilitates the generation of desired glycosylation, such as human-like α2,6-linked sialic acid capping. This engineering approach will aid the production of glycoproteins with improved properties and therapeutic potential.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Nature Biotechnology |
Vol/bind | 33 |
Udgave nummer | 8 |
Sider (fra-til) | 842-844 |
Antal sider | 3 |
ISSN | 1087-0156 |
DOI | |
Status | Udgivet - 10 aug. 2015 |